JP Morgan Reiterates Neutral Rating on Pfizer Inc. (PFE)
Rating Change JP Morgan analysts reiterated a Neutral rating on Pfizer Inc. (NYSE:PFE) on July 08, 2026. Market Context Pfizer Inc.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change JP Morgan analysts reiterated a Neutral rating on Pfizer Inc. (NYSE:PFE) on July 08, 2026. Market Context Pfizer Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on S&P Global Inc. (NYSE:SPGI) on July 08, 2026. Market Context S&P Global Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on July 08, 2026. Market Context Gilead Sciences, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Verizon Communications Inc. (NYSE:VZ) on July 08, 2026. Market Context Verizon Communications Inc.
Read moreRating Change Wells Fargo analysts initiated coverage on Verizon Communications Inc. (NYSE:VZ) with a Equal-Weight rating on July 08, 2026. Market Context Verizon Communications…
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on AT&T Inc. (NYSE:T) on July 08, 2026. Market Context AT&T Inc.
Read moreRating Change Wells Fargo analysts initiated coverage on AT&T Inc. (NYSE:T) with a Underweight rating on July 08, 2026. Market Context AT&T Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on The Charles Schwab Corporation (NYSE:SCHW) on July 08, 2026. Market Context The Charles Schwab Corporation operates in the…
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on AT&T Inc. 5.625% Global Notes d (NYSE:TBC) on July 08, 2026. Market Context AT&T Inc.
Read moreRating Change Wells Fargo analysts initiated coverage on AT&T Inc. 5.625% Global Notes d (NYSE:TBC) with a Underweight rating on July 08, 2026. Market Context AT&T Inc.
Read moreRating Change BNP Paribas analysts reiterated a Outperform rating on PepsiCo, Inc. (NASDAQ:PEP) on July 08, 2026. Market Context PepsiCo, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on July 08, 2026. Market Context Amgen Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on T-Mobile US, Inc. (NASDAQ:TMUS) on July 08, 2026. Market Context T-Mobile US, Inc.
Read moreRating Change Wells Fargo analysts initiated coverage on T-Mobile US, Inc. (NASDAQ:TMUS) with a Equal-Weight rating on July 08, 2026. Market Context T-Mobile US, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Merck & Co., Inc. (NYSE:MRK) on July 08, 2026. Market Context Merck & Co., Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Merck & Co., Inc. (NYSE:MRK) on July 08, 2026. Market Context Merck & Co., Inc.
Read moreRating Change Raymond James analysts reiterated a Market Perform rating on Wells Fargo & Company (NYSE:WFC) on July 08, 2026. Market Context Wells Fargo & Company operates in the…
Read moreRating Change Bernstein analysts reiterated a Outperform rating on Netflix, Inc. (NASDAQ:NFLX) on July 08, 2026. Market Context Netflix, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Johnson & Johnson (NYSE:JNJ) on July 08, 2026. Market Context Johnson & Johnson operates in the Healthcare…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Johnson & Johnson (NYSE:JNJ) on July 08, 2026. Market Context Johnson & Johnson operates in the Healthcare sector. The…
Read more